Quick Answer
IMMUCELL CORP /DE/ reported Stockholders Equity of $27.06 million for fiscal year 2025.
IMMUCELL CORP /DE/ Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $27.06M | -1.7% |
| 2024 | $27.52M | +10.1% |
| 2023 | $24.99M | -17.7% |
| 2022 | $30.38M | -6.7% |
| 2021 | $32.58M | +15.3% |
| 2020 | $28.27M | -2.5% |
| 2019 | $28.99M | +33.3% |
| 2018 | $21.74M | -7.8% |
| 2017 | $23.59M | +19.6% |
| 2016 | $19.72M | +85.8% |
| 2015 | $10.61M | +14.6% |
| 2014 | $9.26M | -1.5% |
| 2013 | $9.40M | +2.2% |
| 2012 | $9.19M | +1.9% |
| 2011 | $9.02M | -2.8% |
| 2010 | $9.28M | -3.5% |
| 2009 | $9.62M | -0.2% |
| 2008 | $9.64M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $29.80M | +12.8% | -0.2% |
| June 30, 2025 | $29.87M | +27.3% | +3.0% |
| March 31, 2025 | $28.99M | +17.7% | +5.4% |
| December 31, 2024 | $27.52M | +10.1% | +4.2% |
| September 30, 2024 | $26.41M | +1.5% | +12.6% |
| June 30, 2024 | $23.46M | -12.7% | -4.8% |
| March 31, 2024 | $24.64M | -12.5% | -1.4% |
| December 31, 2023 | $24.99M | -17.7% | -3.9% |
- IMMUCELL CORP /DE/ showed a decrease of -1.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, IMMUCELL CORP /DE/’s stockholders equity has grown by 180.6% (from $9.64 million to $27.06 million).
- The most recent figure is from IMMUCELL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: